1	Boehringer	boehringer	NNP	p2=JJR	2	nn	_
2	Ingelheim	ingelheim	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	efforts	effort	NNS	_	13	nsubj	6:A1=PPT
5	to	to	TO	_	6	aux	_
6	be	be	VB	pb=be.01	4	infmod	_
7	a	a	DT	_	9	det	_
8	major	major	JJ	_	9	amod	_
9	player	player	NN	_	6	attr	6:A2=PRD
10	in	in	IN	_	9	prep	_
11	the	the	DT	_	16	det	_
12	idiophathic	idiophathic	JJ	_	16	amod	_
13	pulmonary	pulmonary	JJ	p2=NN	0	root	_
14	fibrosis	fibrosis	NN	_	15	nn	_
15	market	market	NN	_	16	nn	_
16	look	look	NN	p2=VB	10	pobj	17:A1=PPT
17	poised	poise	VBN	pb=poise.01	16	partmod	_
18	to	to	TO	_	19	aux	_
19	take	take	VB	pb=take.19	17	xcomp	17:A2=PRP
20	off	off	RP	p2=RB	19	prt	19:C-V
21	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A0=PAG
3	announced	announce	VBD	pb=announce.01	0	root	_
4	results	result	NNS	_	3	dobj	3:A1=PPT
5	from	from	IN	_	4	prep	_
6	its	its	PRP$	_	12	poss	_
7	two	#crd#	CD	_	12	num	_
8	Phase	phase	NNP	p2=NN	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	III	iii	NNP	_	12	nn	_
11	INPULSIS	inpulsis	NNP	_	12	nn	_
12	trials	trial	NNS	_	5	pobj	_
13	Sunday	sunday	NNP	_	3	npadvmod	3:AM-TMP
14	that	that	IN	p2=WDT	19	complm	_
15	the	the	DT	_	18	det	_
16	experimental	experimental	JJ	_	18	amod	_
17	drug	drug	NN	_	18	nn	_
18	nintedanib	nintedanib	NN	p2=NNP	19	nsubj	19:A0
19	reduced	reduce	VBD	p2=VBN|pb=reduce.01	3	ccomp	_
20	the	the	DT	_	22	det	_
21	annual	annual	JJ	_	22	amod	_
22	rate	rate	NN	_	19	dobj	19:A1=PPT
23	of	of	IN	_	22	prep	_
24	decline	decline	NN	_	23	pobj	_
25	in	in	IN	_	24	prep	_
26	forced	force	VBN	p2=JJ|pb=force.01	19	advcl	19:AM-TMP
27	vital	vital	JJ	_	28	amod	_
28	capacity	capacity	NN	_	26	dobj	26:A1=PPT
29	among	among	IN	_	26	prep	26:A2=PRD
30	patients	patient	NNS	_	29	pobj	_
31	over	over	IN	_	26	prep	26:AM-TMP
32	a	a	DT	_	36	det	_
33	52	0	CD	_	35	hmod	_
34	-	-	HYPH	_	35	hyph	_
35	week	week	NN	_	36	nn	_
36	period	period	NN	_	31	pobj	_
37	.	.	.	_	3	punct	_

1	BI	bi	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	the	the	DT	_	4	det	_
4	results	result	NNS	_	5	nsubj	5:A0=CAU
5	showed	show	VBD	pb=show.01	2	ccomp	2:A1=PPT
6	this	this	DT	_	7	det	_
7	result	result	NN	_	5	dobj	5:A1=PPT
8	among	among	IN	_	5	prep	5:A2=GOL
9	48	0	CD	_	10	num	_
10	%	%	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	INPULSIS	inpulsis	NNP	p2=NN	17	nn	_
13	-	-	:	p2=HYPH	10	punct	_
14	I	I	PRP	p2=CD	16	nsubj	_
15	clinical	clinical	JJ	p2=VBP	17	amod	_
16	trial	trial	NN	_	17	nn	_
17	patients	patient	NNS	_	11	pobj	_
18	and	and	CC	_	14	cc	_
19	55	0	CD	_	20	num	_
20	%	%	NN	_	14	conj	_
21	of	of	IN	_	20	prep	_
22	INPULSIS	inpulsis	NNP	p2=NN	24	hmod	_
23	-	-	HYPH	_	24	hyph	_
24	2	0	CD	_	27	nn	_
25	clinical	clinical	JJ	_	26	amod	_
26	trial	trial	NN	_	27	nn	_
27	patients	patient	NNS	_	21	pobj	_
28	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	timing	timing	NN	_	3	nsubj	3:A1=PPT
3	was	be	VBD	pb=be.01	0	root	_
4	somewhat	somewhat	RB	_	5	advmod	_
5	serendipitous	serendipitous	JJ	_	3	acomp	3:A2=PRD
6	,	,	,	_	3	punct	_
7	appearing	appear	VBG	pb=appear.01	3	advcl	3:AM-ADV
8	the	the	DT	_	10	det	_
9	same	same	JJ	_	10	amod	_
10	day	day	NN	_	7	npadvmod	7:AM-TMP
11	that	that	IN	p2=WDT	17	dobj	17:R-A1
12	the	the	DT	_	14	det	_
13	National	national	NNP	_	14	nn	_
14	Institutes	institute	NNPS	_	17	nsubj	17:A0=PAG
15	of	of	IN	_	14	prep	_
16	Health	health	NNP	_	15	pobj	_
17	announced	announce	VBD	pb=announce.01	7	ccomp	7:A1=PPT
18	that	that	IN	_	37	complm	_
19	a	a	DT	_	21	det	_
20	clinical	clinical	JJ	_	21	amod	_
21	trial	trial	NN	_	46	nsubj	22:A1=PPT
22	using	use	VBG	pb=use.01	21	partmod	_
23	already	already	RB	_	25	hmod	27:AM-TMP
24	-	-	HYPH	_	25	hyph	_
25	approved	approve	VBN	_	5	conj	_
26	and	and	CC	_	25	cc	_
27	used	use	VBN	pb=use.01	25	conj	_
28	prednisone	prednisone	NN	p2=JJ	27	dobj	27:A1=PPT
29	and	and	CC	_	28	cc	_
30	azathioprine	azathioprine	NN	p2=VB	28	conj	_
31	with	with	IN	_	27	prep	27:A2=PRP
32	N	n	NNP	p2=NN	34	hmod	_
33	-	-	HYPH	p2=,	34	hyph	_
34	acetylcysteine	acetylcysteine	NNP	p2=NN	31	pobj	_
35	did	do	VBD	_	37	aux	_
36	not	not	RB	_	37	neg	37:AM-NEG
37	slow	slow	VB	p2=JJ|pb=slow.01	25	conj	_
38	progression	progression	NN	_	37	dobj	37:A1=PPT
39	of	of	IN	_	38	prep	_
40	the	the	DT	_	41	det	_
41	disease	disease	NN	_	39	pobj	45:A0=PAG
42	,	,	,	_	41	punct	_
43	which	which	WDT	_	45	nsubj	45:R-A0
44	usually	usually	RB	_	45	advmod	45:AM-TMP
45	kills	kill	VBZ	pb=kill.01	41	rcmod	_
46	patients	patient	NNS	_	45	dobj	45:A1=PPT
47	two	#crd#	CD	_	49	number	_
48	to	to	TO	p2=IN	49	quantmod	_
49	three	#crd#	CD	_	50	num	_
50	years	year	NNS	_	51	npadvmod	_
51	after	after	IN	_	45	prep	45:AM-TMP
52	diagnosis	diagnosis	NN	_	51	pobj	_
53	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	NIH	nih	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	that	that	IN	_	7	complm	_
5	the	the	DT	_	6	det	_
6	trials	trial	NNS	_	7	nsubj	7:A0
7	proved	prove	VBD	pb=prove.01	3	ccomp	3:A1=PPT
8	that	that	IN	_	17	complm	_
9	adding	add	VBG	pb=add.02	17	csubj	17:A0=PAG
10	N	n	NNP	p2=NN	12	hmod	_
11	-	-	HYPH	p2=:	12	hyph	_
12	acetylcysteine	acetylcysteine	NN	p2=NNP	9	dobj	9:A1=PPT
13	to	to	IN	_	9	prep	9:A2=PPT
14	treatments	treatment	NNS	_	13	pobj	_
15	did	do	VBD	_	17	aux	_
16	not	not	RB	_	17	neg	17:AM-NEG
17	slow	slow	VB	p2=JJ|pb=slow.01	7	ccomp	7:A1=PPT
18	progression	progression	NN	_	17	dobj	17:A1=PPT
19	,	,	,	_	17	punct	_
20	which	which	WDT	_	23	nsubjpass	25:R-A1
21	was	be	VBD	_	23	auxpass	_
22	long	long	RB	p2=JJ	23	advmod	23:AM-TMP
23	thought	think	VBN	pb=think.01	17	advcl	_
24	to	to	TO	_	25	aux	_
25	be	be	VB	pb=be.01	23	xcomp	23:C-A1
26	the	the	DT	_	27	det	_
27	case	case	NN	_	25	attr	25:A2=PRD
28	.	.	.	_	3	punct	_

1	The	the	DT	_	6	det	_
2	chronic	chronic	JJ	_	6	amod	_
3	,	,	,	_	6	punct	_
4	progressive	progressive	JJ	_	6	amod	_
5	lung	lung	NN	_	6	nn	_
6	condition	condition	NN	_	7	nsubj	7:A0=PAG
7	scars	scar	VBZ	p2=NNS|pb=scar.01	0	root	_
8	the	the	DT	_	9	det	_
9	lungs	lung	NNS	_	7	dobj	12:A0;7:A1=PPT
10	,	,	,	_	9	punct	_
11	which	which	WDT	_	12	nsubj	12:R-A0
12	leaves	leave	VBZ	pb=leave.01	9	rcmod	_
13	patients	patient	NNS	_	12	dobj	12:A1=DIR
14	increasingly	increasingly	RB	_	15	advmod	_
15	short	short	JJ	p2=RB	12	oprd	12:A2=PRD
16	of	of	IN	_	15	prep	_
17	breath	breath	NN	_	16	pobj	_
18	,	,	,	_	17	punct	_
19	fatigued	fatigued	NN	p2=VBD	17	conj	_
20	,	,	,	_	19	punct	_
21	coughing	coughing	NN	p2=VBG	19	conj	_
22	and	and	CC	_	21	cc	_
23	in	in	IN	_	21	conj	_
24	pain	pain	NN	_	23	pobj	_
25	.	.	.	_	7	punct	_

1	Boehringer	boehringer	NNP	p2=NN	3	nsubjpass	5:A0=PAG;3:A1=PPT
2	is	be	VBZ	_	3	auxpass	_
3	set	set	VBN	pb=set.08	0	root	_
4	to	to	TO	_	5	aux	_
5	present	present	VB	pb=present.01	3	xcomp	3:A2=PRD
6	its	its	PRP$	_	7	poss	_
7	information	information	NN	_	5	dobj	5:A1=PPT
8	as	as	IN	_	7	prep	_
9	a	a	DT	_	13	det	_
10	late	late	RB	p2=JJ	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	breaking	break	VBG	_	13	amod	_
13	presentation	presentation	NN	_	8	pobj	_
14	Tuesday	tuesday	NNP	_	13	npadvmod	_
15	at	at	IN	_	13	prep	_
16	the	the	DT	_	21	det	_
17	American	american	NNP	p2=JJ	19	nn	_
18	Thoracic	thoracic	NNP	_	19	nn	_
19	Society	society	NNP	_	21	nn	_
20	International	international	NNP	_	21	nn	_
21	Conference	conference	NNP	_	15	pobj	_
22	,	,	,	_	3	punct	_
23	and	and	CC	_	3	cc	_
24	may	may	MD	_	25	aux	25:AM-MOD
25	have	have	VB	pb=have.02	3	conj	_
26	to	to	TO	_	27	aux	_
27	elbow	elbow	VB	pb=elbow.01	25	xcomp	_
28	for	for	IN	_	27	prep	27:A1=PPT
29	some	some	DT	_	30	det	_
30	attention	attention	NN	_	28	pobj	_
31	,	,	,	_	25	punct	_
32	since	since	IN	_	35	mark	_
33	InterMune	intermune	NNP	_	35	nsubj	35:A0=PAG
34	also	also	RB	_	35	advmod	35:AM-DIS
35	reported	report	VBD	pb=report.01	25	advcl	_
36	positive	positive	JJ	_	37	amod	_
37	results	result	NNS	_	35	dobj	35:A1
38	Sunday	sunday	NNP	_	35	npadvmod	35:AM-TMP
39	.	.	.	_	3	punct	_

1	In	in	IN	_	6	prep	6:AM-LOC
2	this	this	DT	_	3	det	_
3	case	case	NN	_	1	pobj	_
4	,	,	,	_	6	punct	_
5	it	it	PRP	_	6	nsubj	6:A1=PPT
6	was	be	VBD	pb=be.01	0	root	_
7	Phase	phase	NNP	p2=NN	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	III	iii	NNP	_	10	nn	_
10	data	data	NN	p2=NNS	6	attr	6:A2=PRD
11	about	about	IN	_	10	prep	_
12	its	its	PRP$	_	14	poss	_
13	drug	drug	NN	_	14	nn	_
14	pirfenidone	pirfenidone	NN	_	11	pobj	19:A1=PPT
15	,	,	,	_	14	punct	_
16	which	which	WDT	_	19	nsubjpass	19:R-A1
17	has	have	VBZ	_	19	aux	_
18	been	be	VBN	_	19	auxpass	_
19	approved	approve	VBN	pb=approve.01	14	rcmod	_
20	by	by	IN	_	19	agent	19:A0
21	the	the	DT	_	23	det	_
22	European	european	NNP	_	23	nn	_
23	Commission	commission	NNP	_	20	pobj	_
24	,	,	,	_	19	punct	_
25	but	but	CC	_	19	cc	_
26	not	not	RB	_	27	neg	_
27	by	by	IN	_	19	agent	_
28	the	the	DT	_	29	det	_
29	FDA	fda	NNP	_	27	pobj	_
30	.	.	.	_	6	punct	_

1	InterMune	intermune	NNP	p2=PRP	4	poss	_
2	's	's	POS	_	1	possessive	_
3	ASCEND	ascend	NNP	p2=NN	4	nn	_
4	study	study	NN	_	5	nsubj	5:A0=CAU
5	showed	show	VBD	pb=show.01	0	root	_
6	a	a	DT	_	8	det	_
7	significant	significant	JJ	_	8	amod	_
8	reduction	reduction	NN	_	5	dobj	5:A1=PPT
9	in	in	IN	_	8	prep	_
10	lung	lung	NN	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	function	function	NN	_	13	nn	_
13	loss	loss	NN	_	9	pobj	_
14	among	among	IN	_	8	prep	_
15	patients	patient	NNS	_	14	pobj	_
16	during	during	IN	_	5	prep	5:AM-TMP
17	a	a	DT	_	21	det	_
18	52	0	CD	_	20	hmod	_
19	-	-	HYPH	_	20	hyph	_
20	week	week	NN	_	21	nn	_
21	period	period	NN	_	16	pobj	_
22	.	.	.	_	5	punct	_

1	The	the	DT	_	2	det	_
2	study	study	NN	_	4	nsubj	4:A0=PAG;29:A0=PAG
3	also	also	RB	_	4	advmod	4:AM-DIS
4	found	find	VBD	pb=find.01	0	root	_
5	improvement	improvement	NN	_	4	dobj	4:A1=PPT
6	in	in	IN	_	5	prep	_
7	secondary	secondary	JJ	_	8	amod	_
8	endpoints	endpoint	NNS	_	6	pobj	_
9	,	,	,	_	8	punct	_
10	such	such	JJ	_	11	amod	_
11	as	as	IN	_	8	prep	_
12	a	a	DT	_	13	det	_
13	change	change	NN	_	11	pobj	_
14	in	in	IN	_	13	prep	_
15	the	the	DT	_	21	det	_
16	six	#crd#	CD	_	18	hmod	_
17	-	-	HYPH	p2=:	18	hyph	_
18	minute	minute	NN	_	19	npadvmod	19:A0=PPT
19	walking	walk	VBG	p2=NN|pb=walk.01	20	amod	_
20	distance	distance	NN	_	21	nn	19:AM-LOC
21	test	test	NN	_	14	pobj	_
22	and	and	CC	_	21	cc	_
23	progression	progression	NN	_	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	free	free	JJ	_	26	amod	_
26	survival	survival	NN	_	21	conj	_
27	,	,	,	_	4	punct	_
28	but	but	CC	_	4	cc	_
29	missed	miss	VBD	pb=miss.02	4	conj	_
30	when	when	WRB	_	32	advmod	32:R-AM-TMP
31	it	it	PRP	_	32	nsubj	32:A1=PAG
32	came	come	VBD	pb=come.12	29	advcl	29:AM-TMP
33	to	to	IN	_	32	prep	_
34	the	the	DT	_	36	det	_
35	target	target	NN	_	36	nn	_
36	result	result	NN	p2=VB	33	pobj	_
37	for	for	IN	_	36	prep	_
38	shortness	shortness	NN	_	37	pobj	_
39	of	of	IN	_	38	prep	_
40	breath	breath	NN	_	39	pobj	42:A1=PPT
41	,	,	,	_	40	punct	_
42	known	know	VBN	pb=know.01	40	partmod	_
43	as	as	IN	_	42	prep	42:A2=PRD
44	dyspnea	dyspnea	NN	p2=FW	43	pobj	_
45	.	.	.	_	4	punct	_

1	Jefferies	jefferies	NNP	p2=NNS	2	nn	_
2	analyst	analyst	NN	_	4	nn	_
3	Eun	eun	NNP	_	4	nn	_
4	Yang	yang	NNP	_	5	nsubj	5:A0=PAG
5	wrote	write	VBD	pb=write.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	a	a	DT	_	10	det	_
8	Monday	monday	NNP	_	10	nn	_
9	research	research	NN	_	10	nn	_
10	note	note	NN	_	6	pobj	_
11	that	that	IN	p2=WDT	36	complm	_
12	pulmonologists	pulmonologist	NNS	_	5	dobj	13:A0=PAG
13	attending	attend	VBG	pb=attend.01	12	partmod	_
14	the	the	DT	_	20	det	_
15	American	american	NNP	p2=JJ	17	nn	_
16	Thoracic	thoracic	NNP	_	17	nn	_
17	Society	society	NNP	_	19	nn	_
18	conference	conference	NN	_	19	nn	_
19	view	view	NN	p2=VBP	20	nn	_
20	data	datum	NNS	p2=NN	13	dobj	13:A1=PPT
21	for	for	IN	_	20	prep	_
22	the	the	DT	_	24	det	_
23	two	#crd#	CD	_	24	num	_
24	drugs	drug	NNS	_	21	pobj	_
25	as	as	IN	p2=RB	24	prep	_
26	similar	similar	JJ	_	25	amod	_
27	,	,	,	_	5	punct	_
28	but	but	CC	_	13	cc	_
29	with	with	IN	_	28	prep	_
30	a	a	DT	_	33	det	_
31	slightly	slightly	RB	_	32	advmod	_
32	greater	great	JJR	_	33	amod	_
33	appreciation	appreciation	NN	_	29	pobj	_
34	for	for	IN	_	33	prep	_
35	InterMune	intermune	NNP	_	37	poss	_
36	's	's	POS	_	35	possessive	_
37	pirfenidone	pirfenidone	NN	p2=NNS	34	pobj	_
38	.	.	.	_	5	punct	_

1	Yang	yang	NNP	_	2	nsubj	2:A0=PAG
2	wrote	write	VBD	pb=write.01	0	root	_
3	that	that	IN	_	12	complm	_
4	30	0	CD	_	7	number	_
5	%	%	NN	_	7	quantmod	_
6	to	to	TO	_	7	quantmod	_
7	40	0	CD	_	8	num	_
8	%	%	NN	_	12	nsubj	12:A0=PPT
9	of	of	IN	_	8	prep	_
10	polled	poll	VBN	pb=poll.01	11	amod	_
11	specialists	specialist	NNS	_	9	pobj	10:A1=PPT
12	favored	favor	VBN	p2=VBD|pb=favor.01	2	ccomp	2:A1=PPT
13	pirfenidone	pirfenidone	NN	p2=NNS	12	dobj	12:A1=PAG
14	,	,	,	_	12	punct	_
15	and	and	CC	_	12	cc	_
16	10	0	CD	_	19	number	_
17	%	%	NN	_	19	quantmod	_
18	to	to	TO	p2=IN	19	quantmod	_
19	20	0	CD	_	20	num	_
20	%	%	NN	_	21	nsubj	21:A0=PPT
21	favored	favor	VBN	p2=VBD|pb=favor.01	12	conj	_
22	BI	bi	NNP	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	nintedanib	nintedanib	NN	p2=NNP	21	dobj	21:A1=PAG
25	.	.	.	_	2	punct	_

1	This	this	DT	_	2	det	_
2	material	material	NN	_	6	nsubjpass	6:A1=PRD;8:A1=PPT
3	may	may	MD	_	6	aux	6:AM-MOD;8:AM-MOD
4	not	not	RB	_	6	neg	6:AM-NEG;8:AM-NEG
5	be	be	VB	_	6	auxpass	_
6	published	publish	VBN	pb=publish.01	0	root	_
7	,	,	,	_	6	punct	_
8	broadcast	broadcast	VBN	p2=NN|pb=broadcast.01	6	conj	_
9	,	,	,	_	8	punct	_
10	rewritten	rewrite	VBN	pb=rewrite.01	8	conj	_
11	or	or	CC	_	10	cc	_
12	redistributed	redistribute	VBN	pb=redistribute.01	10	conj	_
13	in	in	IN	_	12	prep	12:AM-MNR
14	any	any	DT	_	15	det	_
15	form	form	NN	_	13	pobj	_
16	without	without	IN	_	12	prep	12:AM-MNR
17	prior	prior	JJ	_	18	amod	_
18	authorization	authorization	NN	_	16	pobj	_
19	.	.	.	_	6	punct	_

